Allergan Targets Strides, Agila Over Generic Eye Drops

Law360, Chicago (May 17, 2013, 1:57 PM EDT) -- Senju Pharmaceutical Co. Ltd., Kyorin Pharmaceutical Co. Ltd. and Allergan Inc. hit Strides Inc. and Agila Specialties Private Ltd. with a patent infringement lawsuit in Delaware federal court Wednesday over their plans to market a generic version of Allergan's Zymar and Zymaxid conjunctivitis eye drops.

The plaintiffs allege that Strides and its Agila affiliate infringed U.S. Patent Number 6,333,045 by filing a abbreviated new drug applications, or ANDAs, with the U.S. Food and Drug Administration seeking approval to make and sell generic copies of Allergan's pink...
To view the full article, register now.